Diabetes Wound Awareness (DWA) PAC Releases Clinical Evidence Review Confirming CAMPs Significantly Reduce Closure Times and Downstream Costs

Comprehensive Review Summarizes Clinical and Economic Benefits of CAMPs for Chronic and Hard-to-Heal Wound Care

September 15, 2025 -- The Diabetic Wound Awareness PAC (DWA) today released a research brief on the proven efficacy of Cellular, Acellular, and Matrix-like Products (CAMPs) in treating chronic wounds. The review underscores the significant benefits of CAMPs in improving wound closure rates, reducing recurrence and mortality, and providing cost-effective treatment for patients suffering from chronic wounds.

Chronic wounds, which affect 16.4% of individuals enrolled in Medicare, pose a significant healthcare challenge, particularly among seniors, people living in nursing facilities and other long term care facilities, homebound populations, veterans, and those with diabetes. The underlying conditions contributing to chronic wound prevalence, such as diabetes and vascular disease, are on the rise and are expected to lead to increased Medicare spending.

The evidence review reveals that CAMPs have emerged as a highly effective treatment for chronic wounds, with meta-analyses of clinical trials demonstrating a 55-72% increase in wound closure rates compared to standard care. Real-world evidence from Medicare claims data shows that CAMPs reduce wound recurrence by 80-91% and one-year mortality by 23-26%. Furthermore, CAMPs provide cost-effective treatment for patients suffering from chronic wounds by preventing expensive complications, emergency visits, and hospitalizations.

The DWA PAC is committed to raising awareness about the efficacy and value of CAMPs as a life-saving and life-changing product in wound care management and treatment, especially for the millions of Americans with diabetes. Preserving patient access to CAMPs and ensuring that the critical products are available and accessible for patients in all settings of care is critical for improving outcomes, reducing the overall burden of chronic wounds, and reducing long-term healthcare costs on our nation’s healthcare system.

To access the full evidence review, please visit https://www.dwapac.com/evidence-review-summaries

About Diabetes Wound Awareness PAC:

The Diabetic Wound Awareness PAC was created to represent patients and their families, medical providers, researchers and scientists, and industry to ensure fairness, equity, and availability of wound-healing coverage for all. For more information, visit: https://www.dwapac.com/

Paid for by Diabetic Wound Awareness (DWA) PAC, 555 E. North Lane, Suite 5000, Building D, Conshohocken, Pennsylvania 19428. Not authorized by any candidate or candidate’s committee. Contributions to the Independent Expenditure Account of Diabetic Wound Awareness (DWA) PAC are not deductible as charitable contributions for federal income tax purposes. Contributions from federal contractors and foreign nationals are prohibited. Federal Law requires Diabetic Wound Awareness (DAW) PAC to use best efforts to collect and report to the Federal Election Commission the name, mailing address, occupation and employer of each contributor, and any contributor needs to supply such information.